» Articles » PMID: 36349214

and Co-Infection Due to Inhalation of Biogas in Immunocompetent Patients: A Case Series

Overview
Publisher Dove Medical Press
Date 2022 Nov 9
PMID 36349214
Authors
Affiliations
Soon will be listed here.
Abstract

This is the first report describing co-infection of and caused by biogas inhalation in two people without underlying medical conditions. Two patients fell into the same pig manure pit at the same time while rescuing another patient (this person died in a few hours) and inhaled biogas. Both patients were diagnosed with pulmonary fungal disease and developed acute liver failure around Day 52. Their results were negative for the 1,3-β-d-glucan test and weakly positive for the galactomannan test. They were treated with amphotericin B and/or posaconazole without surgery. The patient in case 2 required amphotericin B deoxycholate aerosol inhalation to complete the treatment. Both patients recovered completely. For patients with mucormycosis confined to the lungs who cannot tolerate intravenous drip amphotericin B, increasing the dose of nebulised administration maybe a salvage regimen.

Citing Articles

Pulmonary mucormycosis in an immunocompetent young female: a case report and literature review.

Zhang X, Wu Z, Shao S Front Med (Lausanne). 2025; 11():1491489.

PMID: 39776843 PMC: 11703827. DOI: 10.3389/fmed.2024.1491489.


A Lateral-Flow Device for the Rapid Detection of Species.

Davies G, Thornton C Diagnostics (Basel). 2024; 14(8).

PMID: 38667492 PMC: 11048963. DOI: 10.3390/diagnostics14080847.


Scedosporiosis and lomentosporiosis: modern perspectives on these difficult-to-treat rare mold infections.

Neoh C, Chen S, Lanternier F, Tio S, Halliday C, Kidd S Clin Microbiol Rev. 2024; 37(2):e0000423.

PMID: 38551323 PMC: 11237582. DOI: 10.1128/cmr.00004-23.


A systemic infection involved in lung, brain and spine caused by Scedosporium apiospermum species complex after near-drowning: a case report and literature review.

Yan P, Chen J, Wang H, Jia Q, Xie J, Mo G BMC Infect Dis. 2024; 24(1):342.

PMID: 38515075 PMC: 10956195. DOI: 10.1186/s12879-023-08279-9.

References
1.
Lamoth F, Kontoyiannis D . Therapeutic Challenges of Non- Invasive Mold Infections in Immunosuppressed Patients. Antimicrob Agents Chemother. 2019; 63(11). PMC: 6811444. DOI: 10.1128/AAC.01244-19. View

2.
Sharma A, Goel A . Mucormycosis: risk factors, diagnosis, treatments, and challenges during COVID-19 pandemic. Folia Microbiol (Praha). 2022; 67(3):363-387. PMC: 8881997. DOI: 10.1007/s12223-021-00934-5. View

3.
Cortez K, Roilides E, Quiroz-Telles F, Meletiadis J, Antachopoulos C, Knudsen T . Infections caused by Scedosporium spp. Clin Microbiol Rev. 2008; 21(1):157-97. PMC: 2223844. DOI: 10.1128/CMR.00039-07. View

4.
Patterson T, Thompson 3rd G, Denning D, Fishman J, Hadley S, Herbrecht R . Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016; 63(4):e1-e60. PMC: 4967602. DOI: 10.1093/cid/ciw326. View

5.
Feng J, Sun X . Characteristics of pulmonary mucormycosis and predictive risk factors for the outcome. Infection. 2018; 46(4):503-512. DOI: 10.1007/s15010-018-1149-x. View